Mereo Biopharma Group PLC
NASDAQ:MREO
Mereo Biopharma Group PLC
NASDAQ:MREO
Price:
3.01 USD
-2.9%
Market Closed
Updated:
May 8, 2024
Mereo Biopharma Group PLC
Total Other Income
|
Mereo Biopharma Group PLC
Total Other Income Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Mereo Biopharma Group PLC
NASDAQ:MREO
|
Total Other Income
£320k
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Total Other Income
-$5.4m
|
CAGR 3-Years
-160%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Total Other Income
$261k
|
CAGR 3-Years
-42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Total Other Income
-£897k
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Total Other Income
£1.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mereo Biopharma Group PLC's Total Other Income?
Total Other Income
320k
GBP
320k
GBP
Based on the financial report for Dec 31, 2022, Mereo Biopharma Group PLC's Total Other Income amounts to 320k GBP.
What is Mereo Biopharma Group PLC's Total Other Income growth rate?
Total Other Income CAGR 3Y
10%
10%
The average annual Total Other Income growth rates for Mereo Biopharma Group PLC have been 10% over the past three years .
You don't have any saved screeners yet
